Long-term survival in patients with node-positive breast cancer who undergo sentinel lymph node biopsy alone after neoadjuvant chemotherapy: meta-analysis.
Stephen KeelanMichael R BolandÉanna J RyanLaura R MoranMatthew G DaveyAngus J LloydSami ElwahabArnold D K HillPublished in: The British journal of surgery (2022)
Patients who are initially node-positive and who achieve a complete clinical/radiological axillary response after NACT with a subsequent negative SLNB have high rates of DFS and OS after 5 years. Patients with residual disease have significantly reduced DFS and further axillary treatment may still be warranted.
Keyphrases
- sentinel lymph node
- neoadjuvant chemotherapy
- lymph node
- positive breast cancer
- early stage
- systematic review
- locally advanced
- end stage renal disease
- ejection fraction
- newly diagnosed
- chronic kidney disease
- peritoneal dialysis
- ultrasound guided
- rectal cancer
- squamous cell carcinoma
- randomized controlled trial
- patient reported outcomes
- radiation therapy
- case control